2-(4-Ethylpiperazin-1-yl)-7-fluoro-3-(4-methoxyphenyl)-quinazolin-4(3H)-one

ID: ALA4465513

PubChem CID: 155531068

Max Phase: Preclinical

Molecular Formula: C21H23FN4O2

Molecular Weight: 382.44

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1CCN(c2nc3cc(F)ccc3c(=O)n2-c2ccc(OC)cc2)CC1

Standard InChI:  InChI=1S/C21H23FN4O2/c1-3-24-10-12-25(13-11-24)21-23-19-14-15(22)4-9-18(19)20(27)26(21)16-5-7-17(28-2)8-6-16/h4-9,14H,3,10-13H2,1-2H3

Standard InChI Key:  LDVRRMDXKLICNV-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   31.5141  -14.5856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5130  -15.4051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2210  -15.8141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2192  -14.1767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9278  -14.5820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9312  -15.4072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6436  -15.8146    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.3572  -15.4013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3538  -14.5761    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.6368  -14.1642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6323  -13.3470    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.0592  -14.1657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7684  -14.5738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4744  -14.1637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4723  -13.3456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7583  -12.9394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0553  -13.3519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0660  -15.8080    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.1808  -12.9313    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.8049  -15.8132    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   35.0651  -16.6299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7699  -17.0365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4789  -16.6294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.4786  -15.8113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7693  -15.4002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8908  -13.3359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1861  -17.0388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8943  -16.6309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  9 12  1  0
  8 18  1  0
 15 19  1  0
  2 20  1  0
 18 21  1  0
 18 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 19 26  1  0
 23 27  1  0
 27 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4465513

    ---

Associated Targets(Human)

TRPV4 Tchem Transient receptor potential cation channel subfamily V member 4 (774 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 382.44Molecular Weight (Monoisotopic): 382.1805AlogP: 2.68#Rotatable Bonds: 4
Polar Surface Area: 50.60Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.58CX LogP: 3.11CX LogD: 2.71
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.69Np Likeness Score: -1.62

References

1. Atobe M, Nagami T, Muramatsu S, Ohno T, Kitagawa M, Suzuki H, Ishiguro M, Watanabe A, Kawanishi M..  (2019)  Discovery of Novel Transient Receptor Potential Vanilloid 4 (TRPV4) Agonists as Regulators of Chondrogenic Differentiation: Identification of Quinazolin-4(3 H)-ones and in Vivo Studies on a Surgically Induced Rat Model of Osteoarthritis.,  62  (3): [PMID:30629441] [10.1021/acs.jmedchem.8b01615]

Source